Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 2/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL540751 | 0.96 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL3207425 | 0.93 | ATM (0.46) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL4895739 | 0.90 | ALDH1A1 (0.39) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL487322 | 0.89 | ATM (0.41) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL1602604 | 0.85 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL1527050 | 0.84 | ATM (0.64) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL4893048 | 0.84 | TSHR (0.42) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL24797 | 0.83 | ATM (0.70) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL4888147 | 0.82 | ATM (0.48) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL1452125 | 0.81 | HCAR2 (0.62) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | FEMASYS INC. (US) | 2026-04-21 | — | — | US | claimed |
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | FEMASYS INC (US) | 2026-03-05 | — | — | US | claimed |
| EP-4613213-A2 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | Femasys, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| EP-3579890-B1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS INC (US) | 2025-06-18 | — | — | EP | claimed |
| US-20230390105-A1 | METHODS AND DEVICES FOR CONTROLLED DELIVERY | POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC | 2023-12-07 | — | — | US | claimed |
| US-20230364304-A1 | METHODS OF FORMING BONE INTERFACE SCAFFOLDS | Sparta Biopharma LLC (US) | 2023-11-16 | — | — | US | claimed |
| US-11364324-B2 | Methods of forming bone interface scaffolds | SPARTA BIOPHARMA INC. (US) | 2022-06-21 | — | — | US | claimed |
| US-20220054709-A1 | METHODS OF FORMING BONE INTERFACE SCAFFOLDS | SPARTA BIOPHARMA INC. | 2022-02-24 | — | — | US | claimed |
| EP-3787533-A1 | METHODS AND DEVICES FOR CONTROLLED DELIVERY | Femasys, Inc. (US) | 2021-03-10 | — | — | EP | claimed |
| WO-2018148453-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS, INC. (US) | 2018-08-16 | — | — | WO | claimed |
| WO-2006034157-A2 | PACKAGE COMPONENTS FOR RADIOCHEMICAL STERILIZATION | POLY-MED, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| EP-0952171-B1 | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof | POLY MED INC (US) | 2006-01-04 | — | — | EP | claimed |
| US-20050042197-A1 | Stabilized polyester/cyanoacrylate tissue adhesive formulation | POLY-MED, INC. | 2005-02-24 | — | — | US | claimed |
| US-20040199207-A1 | Polyester/cyanoacrylate tissue adhesive compositions | POLY-MED, INC. | 2004-10-07 | — | — | US | claimed |
| US-6699940-B2 | Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom | POLY MED, INC. | 2004-03-02 | — | — | US | claimed |
| US-6632450-B1 | Adherable biomaterial patches and methods for producing and for using same | Gregory, Kenton | 2003-10-14 | — | — | US | claimed |
| US-20030105256-A1 | Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom | POLY-MED, INC. | 2003-06-05 | — | — | US | claimed |
| US-20030069535-A1 | Stabilized polyester/cyanoacrylate tissue adhesive formulation | POLY-MED, INC. | 2003-04-10 | — | — | US | claimed |
| US-6413539-B1 | BLOCK POLYMER | POLY-MED, INC. | 2002-07-02 | — | — | US | claimed |
| EP-0952171-A2 | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof | Poly-Med Inc. (US) | 1999-10-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | PGF, ACR, FGB | ATM 446/4885HCAR2 465/4885MAPT 1368/4885 |
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | MKI67, ACR, PGF | ATM 171/4885HCAR2 1197/4885MAPT 2417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.